Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Stress integration by an ascending adrenergic-melanocortin circuit
    Published on 2024-02-06
    2 years ago
  • Brain connectivity changes to fast versus slow dopamine increases
    Published on 2024-02-06
    2 years ago
  • Network-based drug repurposing for schizophrenia
    Published on 2024-02-05
    2 years ago
  • Identifying novel proteins for suicide attempt by integrating proteomes from brain and blood with genome-wide association data
    Published on 2024-02-04
    2 years ago
  • Heartbeat-evoked neural response abnormalities in generalized anxiety disorder during peripheral adrenergic stimulation
    Published on 2024-01-29
    2 years ago
  • Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
    Published on 2024-01-28
    2 years ago
  • Data-driven connectivity profiles relate to smoking cessation outcomes
    Published on 2024-01-26
    2 years ago
« Previous 1 … 68 69 70 71 72 … 143 Next »
Journal of Psychopharmacology
  • Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning
    Published on 2022-03-04
    4 years ago
  • Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ)
    Published on 2022-03-02
    4 years ago
  • The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder
    Published on 2022-02-25
    4 years ago
  • Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine
    Published on 2022-02-25
    4 years ago
  • A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults
    Published on 2022-02-15
    4 years ago
  • LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking
    Published on 2022-02-02
    4 years ago
  • Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
    Published on 2022-02-02
    4 years ago
« Previous 1 … 68 69 70 71 72 … 134 Next »
European Neuropsychopharmacology
  • Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment
    Published on 2022-07-11
    3 years ago
  • Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder
    Published on 2022-07-08
    3 years ago
  • Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?
    Published on 2022-07-08
    3 years ago
  • Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders
    Published on 2022-07-08
    3 years ago
  • Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan
    Published on 2022-07-07
    3 years ago
  • The potential of TAAR1 agonists in bipolar disorder
    Published on 2022-07-06
    3 years ago
  • The antipsychotic paradox: Lessons regarding determinants of premature mortality
    Published on 2022-07-03
    3 years ago
« Previous 1 … 68 69 70 71 72 … 154 Next »

   Pharma Pub